多发性骨髓瘤诊断与治疗：现状与挑战

Diagnosis and treatment of multiple myeloma： current status and future challenges

过去的十年中，国内外多发性骨髓瘤（MM）的发病机制、危险分层以及治疗等方面的研究取得了突破性进展。新药的不断出现、嵌合抗原受体重定向T细胞的问世以及异基因造血干细胞移植的开展，使MM患者预后得到了极大改善。

In the past ten years, much progress has been made in the pathophysiology, risk-stratification, and treatment of multiple myeloma （MM）. Emerging paradigms in the therapy of MM including new drugs, chimeric antigen receptor-modified T cells, and allogeneic stem cell transplantation have improved the prognosis of MM patients.